Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017

Latest news articles

Added 4 days ago Drug news

FDA approves Mvasi (bevacizumab-awwb) biosimilar for non-small cell lung cancer, for metastatic colorectal cancer, glioblastoma, metastatic renal cell carcinoma and carcinoma of the cervix.- Amgen and Allergan.

Amgen and Allergan announced that the FDA has approved Mvasi (bevacizumab-awwb) for all eligible indications of the reference product, Avastin...

Added 10 days ago Drug news

Phase III CheckMate -214 study of Opdivo plus Yervoy (nivolumab + ipilimumab) in untreated advanced or metastatic renal cell carcinoma meets endpoint and advisory committee recommends halting study.- BMS.

Bristol-Myers Squibb announced that a Phase III CheckMate -214 study evaluating Opdivo plus Yervoy (nivolumab + ipilimumab) in patients with...

Added 18 days ago Drug news

European Commission approves Fotivda (tivozanib) for the treatment of patients with advanced renal cell carcinoma.-Aveo Oncology + EUSA Pharma.

Aveo Oncology has announced that the European Commission (EC) has approved Fotivda (tivozanib) for the treatment of adult patients with...

Search all news articles for Cancer of kidney and renal pelvis
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Breakthrough Cancer Pain Learning Zone

Invitation to watch the online broadcast of the BeCOn OWN event 'Shifting paradigms in BTcP management' on June 16 2017.

Visit Breakthrough Cancer Pain Learning Zone

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria

+ 3 more

Visit Chronic Spontaneous Urticaria (CSU)

Guidelines

Guidelines on Renal Cell Carcinoma

The European Association of Urology (EAU) Renal Cell Cancer (RCC) Guidelines Panel has compiled these clinical guidelines to provide urologists...

Added 1 year ago

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best...

Added 3 years ago

Search all guidelines for Cancer of kidney and renal pelvis
 

Journal articles

Specific immunotherapy in renal cancer: a systematic review.

Renal cell cancer (RCC) is the tenth most common malignancy in adults. In recent years, several approaches of active and passive immunotherapy have been studied extensively in clinical trials of patients with RCC.

Added 4 months ago

Lenvatinib for use in combination with everolimus for the treatment of patients with advanced renal cell carcinoma following one prior anti-angiogenic therapy.

Introduction: In patients with mRCC options for second line therapies, following progression on anti-angiogenic agents, that demonstrate a survival advantage in clinical trials have been limited.

Added 5 months ago

Cabozantinib: an Active Novel Multikinase Inhibitor in Renal Cell Carcinoma.

Clear cell renal cell carcinoma (RCC) is characterized by inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene. VHL loss drives tumor angiogenesis and accounts for the clinical activity ...

Added 5 months ago

Search all journal articles for Cancer of kidney and renal pelvis
 

Clinical trials

Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)

The purpose of this study is to compare the objective response rate, progression free survival and the overall survival of Nivolumab combined with Ipilimumab to Sunitinib monotherapy in patients with previously untreated Renal Cell Cancer.

Added 4 years ago

Search all clinical trials for Cancer of kidney and renal pelvis
 
Fiona Holland

Fiona worked in the fitness and wellness industry in the US for 13 years, supporting behaviour change in a variety of settings. Fiona’s research interests lie broadly within health and wellbeing. She is particularly interested in qualitative methodologies in the areas of body image ... Read more

What to say and do when someone has cancer

Ahead of World Cancer Day on Saturday (February 4), Fiona Holland, Psychology Lecturer, discusses what to say and what not to say to someone with cancer.